Salesforce Agentforce Life Sciences to unify Moderna’s global commercial operations

This article is an abridged translation of “Salesforce Agentforce Life Sciences to Unify Moderna’s Global Commercial Operations,” published in the United States on April 28, 2026. The official language of the article is English, and the English version prevails for its content and interpretation. Salesforce announced that biopharmaceutical company Moderna has adopted Agentforce Life Sciences for Customer Engagement to unify its global commercial operations. This will help Moderna streamline customer engagement, field service, and customer service operations, gain a 360-degree understanding of customers, and realize its vision of a single integrated platform for delivering superior customer experiences. The integrated platform will bring together data, AI, and customer engagement across commercial users in multiple regions, enabling the following capabilities: Unified Customer 360 with trusted data: Moderna will integrate customer data from SAP, e-commerce, and systems across multiple regions to create a single source of truth for interactions with healthcare professionals. By using IQVIA OneKey, Moderna will gain access to trusted, real-time reference data and private, secure master data management. AI-powered commercial excellence: Moderna’s field teams will use Agentforce to receive next-best-action recommendations, automate cycle planning, and streamline call reporting. This will help commercial users worldwide engage more effectively with healthcare professionals based on real-time insights and intelligent recommendations. Global omnichannel marketing at scale: As Moderna expands its marketing activities globally, the platform will enable integrated cross-channel marketing and support both commercial engagement and customer service through personalized, data-driven campaigns. A platform built for integration: Salesforce’s open ecosystem and integration-first architecture will connect commercial, medical, patient services, and contact center operations to support Moderna’s integrated platform. This will allow Moderna to scale quickly while leveraging existing Agentforce Life Sciences investments and avoiding vendor lock-in. Joe Ferraro, general manager of Agentforce Life Sciences, said: “Moderna has always embraced innovation, and this collaboration reflects its commitment to building a modern, AI-driven commercial organization. With Agentforce Life Sciences, Moderna will build a platform that unifies data, AI, and automation, enabling teams to create more meaningful customer engagement at global scale.” Salesforce said additional official resources provide more information on how it is leading the next era of life sciences transformation, customer perspectives from organizations using Agentforce Life Sciences, its roadmap and transition framework, and its open ecosystem and partner network. Salesforce helps companies of every size transform into agentic enterprises by unifying people, AI agents, applications, and data on a single trusted platform to drive growth and innovation. More information is available at salesforce.com/jp. Services or features mentioned in this press release, other press releases, or official statements that are not yet generally available may not be available now and may not be delivered on schedule or at all. Customers should make purchasing decisions based on currently available functionality.